by Reacta Healthcare | Nov 4, 2024 | Business News, Milestones
Reacta Healthcare secures first US patent Posted on August 8, 2022 The patent has been granted for challenge meals, which are used in oral food challenges (OFCs). Unique to the Reacta formulation is Reacta’s ability to create a non-allergen formulation that is...
by Reacta Healthcare | Nov 4, 2024 | Business News, Milestones
UK Food Allergy Diagnostic company, Reacta Biotech, achieves MHRA GMP licence Posted on June 16, 2021 Pursuant to a capital raise in 2020, Reacta has achieved its goal of securing an MHRA site license This license opens up significant opportunities for the companies...
by Reacta Healthcare | Nov 4, 2024 | Business News, Milestones
Reacta Biotech making progress on peanut diagnostic product Posted on May 19, 2020 Deeside-based Reacta Biotech is on course to secure a market authorisation for its peanut diagnostic product within the next two years as global activity to treat peanut allergies...
